Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues

Quarterly Journal of Nuclear Medicine

Volumn 43, Issue 4, 1999, Pages 356-366

  De Jong, M ^a   Breeman, W A P ^a   Bernard, H F ^a   Kooij, P P M ^a   Slooter, G D ^a   Van Eijck, C H J ^a   Kwekkeboom, D J ^a   Valkema, R ^a   Macke, H R ^a   Krenning, E P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Neuroendocrine tumors; Radioisotopes; Somatostatin analogues and derivatives; Therapeutic use

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; OCTREOTIDE; OCTREOTIDE[3 TYROSINE]; PENTETATE INDIUM IN 111; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; YTTRIUM 90;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPHOCYTE DEPLETION; MALE; NEUROENDOCRINE TUMOR; NONHUMAN; PHASE 1 CLINICAL TRIAL; RADIATION DOSE; RADIATION RESPONSE; RADIOISOTOPE THERAPY; RAT; THROMBOCYTOPENIA; TUMOR REGRESSION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; INDIUM RADIOISOTOPES; NEUROENDOCRINE TUMORS; OCTREOTIDE; PANCREATIC NEOPLASMS; RATS; RATS, INBRED LEW; YTTRIUM RADIOISOTOPES;

EID: 0033491885     PISSN: 11243937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)